XERIS BIOPHARMA HOLDINGS, INC. Debt Securities, Available-for-sale, Amortized Cost
XERIS BIOPHARMA HOLDINGS, INC. (XERS) had Debt Securities, Available-for-sale, Amortized Cost of $10.16 million as of 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2025-03-06
- 2024-09-30: Debt Securities, Available-for-sale, Amortized Cost $10.16M.
- 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost $19.97M.
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $24.67M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $5.00M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2024-09-30 | $10.16M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $19.97M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $24.67M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.00M 10-K · filed 2025-03-06 |
| 2023-09-30 | $19.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $34.55M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $44.12M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $9.34M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $16.24M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $28.42M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $35.17M 10-K · filed 2023-03-08 |
| 2021-09-30 | $33.49M 10-Q · filed 2021-11-10 |
| 2020-12-31 | $96.16M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |